Enanta Announces New Data on VIEKIRA PAK in Patients with Chronic Hepatitis C Virus Infection With or Without Compensated Cirrhosis
November 15, 2015 at 10:00 AM EST
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) announced Saturday, new data from AbbVie's ongoing Phase 3b TOPAZ-II study ...